List of Tables
Table 1. Oncolytic Virus Therapy Market Trends
Table 2. Oncolytic Virus Therapy Market Drivers & Opportunity
Table 3. Oncolytic Virus Therapy Market Challenges
Table 4. Oncolytic Virus Therapy Market Restraints
Table 5. Global Oncolytic Virus Therapy Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Oncolytic Virus Therapy Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Oncolytic Virus Therapy Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Oncolytic Virus Therapy Product Type
Table 9. Key Companies Time to Begin Mass Production of Oncolytic Virus Therapy
Table 10. Global Oncolytic Virus Therapy Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus Therapy as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Oncolytic Virus Therapy Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Oncolytic Virus Therapy Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Oncolytic Virus Therapy Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Oncolytic Virus Therapy Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Oncolytic Virus Therapy Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Oncolytic Virus Therapy Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Oncolytic Virus Therapy Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Oncolytic Virus Therapy Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Oncolytic Virus Therapy Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Oncolytic Virus Therapy Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Oncolytic Virus Therapy Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Oncolytic Virus Therapy Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Oncolytic Virus Therapy Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Oncolytic Virus Therapy Sales Value by Region (2019-2024) & (%)
Table 27. Global Oncolytic Virus Therapy Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Oncolytic Virus Therapy Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Oncolytic Virus Therapy Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Oncolytic Virus Therapy Sales Value, (2025-2030) & (US$ Million)
Table 31. Amgen Basic Information List
Table 32. Amgen Description and Business Overview
Table 33. Amgen Oncolytic Virus Therapy Products, Services and Solutions
Table 34. Revenue (US$ Million) in Oncolytic Virus Therapy Business of Amgen (2019-2024)
Table 35. Amgen Recent Developments
Table 36. Oncolytics Biotech Basic Information List
Table 37. Oncolytics Biotech Description and Business Overview
Table 38. Oncolytics Biotech Oncolytic Virus Therapy Products, Services and Solutions
Table 39. Revenue (US$ Million) in Oncolytic Virus Therapy Business of Oncolytics Biotech (2019-2024)
Table 40. Oncolytics Biotech Recent Developments
Table 41. Viralytics Basic Information List
Table 42. Viralytics Description and Business Overview
Table 43. Viralytics Oncolytic Virus Therapy Products, Services and Solutions
Table 44. Revenue (US$ Million) in Oncolytic Virus Therapy Business of Viralytics (2019-2024)
Table 45. Viralytics Recent Developments
Table 46. Transgene SA Basic Information List
Table 47. Transgene SA Description and Business Overview
Table 48. Transgene SA Oncolytic Virus Therapy Products, Services and Solutions
Table 49. Revenue (US$ Million) in Oncolytic Virus Therapy Business of Transgene SA (2019-2024)
Table 50. Transgene SA Recent Developments
Table 51. Oncolys BioPharma Basic Information List
Table 52. Oncolys BioPharma Description and Business Overview
Table 53. Oncolys BioPharma Oncolytic Virus Therapy Products, Services and Solutions
Table 54. Revenue (US$ Million) in Oncolytic Virus Therapy Business of Oncolys BioPharma (2019-2024)
Table 55. Oncolys BioPharma Recent Developments
Table 56. Targovax Basic Information List
Table 57. Targovax Description and Business Overview
Table 58. Targovax Oncolytic Virus Therapy Products, Services and Solutions
Table 59. Revenue (US$ Million) in Oncolytic Virus Therapy Business of Targovax (2019-2024)
Table 60. Targovax Recent Developments
Table 61. PsiOxus Therapeutics Basic Information List
Table 62. PsiOxus Therapeutics Description and Business Overview
Table 63. PsiOxus Therapeutics Oncolytic Virus Therapy Products, Services and Solutions
Table 64. Revenue (US$ Million) in Oncolytic Virus Therapy Business of PsiOxus Therapeutics (2019-2024)
Table 65. PsiOxus Therapeutics Recent Developments
Table 66. SillaJen Biotherapeutics Basic Information List
Table 67. SillaJen Biotherapeutics Description and Business Overview
Table 68. SillaJen Biotherapeutics Oncolytic Virus Therapy Products, Services and Solutions
Table 69. Revenue (US$ Million) in Oncolytic Virus Therapy Business of SillaJen Biotherapeutics (2019-2024)
Table 70. SillaJen Biotherapeutics Recent Developments
Table 71. Sorrento Therapeutics Basic Information List
Table 72. Sorrento Therapeutics Description and Business Overview
Table 73. Sorrento Therapeutics Oncolytic Virus Therapy Products, Services and Solutions
Table 74. Revenue (US$ Million) in Oncolytic Virus Therapy Business of Sorrento Therapeutics (2019-2024)
Table 75. Sorrento Therapeutics Recent Developments
Table 76. Lokon Pharma Basic Information List
Table 77. Lokon Pharma Description and Business Overview
Table 78. Lokon Pharma Oncolytic Virus Therapy Products, Services and Solutions
Table 79. Revenue (US$ Million) in Oncolytic Virus Therapy Business of Lokon Pharma (2019-2024)
Table 80. Lokon Pharma Recent Developments
Table 81. Genelux Corporation Basic Information List
Table 82. Genelux Corporation Description and Business Overview
Table 83. Genelux Corporation Oncolytic Virus Therapy Products, Services and Solutions
Table 84. Revenue (US$ Million) in Oncolytic Virus Therapy Business of Genelux Corporation (2019-2024)
Table 85. Genelux Corporation Recent Developments
Table 86. Vyriad Basic Information List
Table 87. Vyriad Description and Business Overview
Table 88. Vyriad Oncolytic Virus Therapy Products, Services and Solutions
Table 89. Revenue (US$ Million) in Oncolytic Virus Therapy Business of Vyriad (2019-2024)
Table 90. Vyriad Recent Developments
Table 91. TILT Biotherapeutics Basic Information List
Table 92. TILT Biotherapeutics Description and Business Overview
Table 93. TILT Biotherapeutics Oncolytic Virus Therapy Products, Services and Solutions
Table 94. Revenue (US$ Million) in Oncolytic Virus Therapy Business of TILT Biotherapeutics (2019-2024)
Table 95. TILT Biotherapeutics Recent Developments
Table 96. Cold Genesys Basic Information List
Table 97. Cold Genesys Description and Business Overview
Table 98. Cold Genesys Oncolytic Virus Therapy Products, Services and Solutions
Table 99. Revenue (US$ Million) in Oncolytic Virus Therapy Business of Cold Genesys (2019-2024)
Table 100. Cold Genesys Recent Developments
Table 101. Key Raw Materials Lists
Table 102. Raw Materials Key Suppliers Lists
Table 103. Oncolytic Virus Therapy Downstream Customers
Table 104. Oncolytic Virus Therapy Distributors List
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
Table 108. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Oncolytic Virus Therapy Product Picture
Figure 2. Global Oncolytic Virus Therapy Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Oncolytic Virus Therapy Sales Value (2019-2030) & (US$ Million)
Figure 4. Oncolytic Virus Therapy Report Years Considered
Figure 5. Global Oncolytic Virus Therapy Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Oncolytic Virus Therapy Revenue in 2023
Figure 7. Oncolytic Virus Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. HSV-based Oncolytic Viruses Picture
Figure 9. Adenoviruses-based Oncolytic Viruses Picture
Figure 10. Vaccinia Virus-based Oncolytic Viruses Picture
Figure 11. Vesicular Stomatitis Virus-based Oncolytic Viruses Picture
Figure 12. Newcastle Disease Virus-based Oncolytic Viruses Picture
Figure 13. Global Oncolytic Virus Therapy Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Oncolytic Virus Therapy Sales Value Market Share by Type, 2023 & 2030
Figure 15. Product Picture of Melanoma
Figure 16. Product Picture of Prostate Cancer
Figure 17. Product Picture of Breast Cancer
Figure 18. Product Picture of Ovarian Cancer
Figure 19. Product Picture of Others
Figure 20. Global Oncolytic Virus Therapy Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 21. Global Oncolytic Virus Therapy Sales Value Market Share by Application, 2023 & 2030
Figure 22. North America Oncolytic Virus Therapy Sales Value (2019-2030) & (US$ Million)
Figure 23. North America Oncolytic Virus Therapy Sales Value by Country (%), 2023 VS 2030
Figure 24. Europe Oncolytic Virus Therapy Sales Value (2019-2030) & (US$ Million)
Figure 25. Europe Oncolytic Virus Therapy Sales Value by Country (%), 2023 VS 2030
Figure 26. Asia Pacific Oncolytic Virus Therapy Sales Value (2019-2030) & (US$ Million)
Figure 27. Asia Pacific Oncolytic Virus Therapy Sales Value by Country (%), 2023 VS 2030
Figure 28. South America Oncolytic Virus Therapy Sales Value (2019-2030) & (US$ Million)
Figure 29. South America Oncolytic Virus Therapy Sales Value by Country (%), 2023 VS 2030
Figure 30. Middle East & Africa Oncolytic Virus Therapy Sales Value (2019-2030) & (US$ Million)
Figure 31. Middle East & Africa Oncolytic Virus Therapy Sales Value by Country (%), 2023 VS 2030
Figure 32. Key Countries/Regions Oncolytic Virus Therapy Sales Value (%), (2019-2030)
Figure 33. United States Oncolytic Virus Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 34. United States Oncolytic Virus Therapy Sales Value by Type (%), 2023 VS 2030
Figure 35. United States Oncolytic Virus Therapy Sales Value by Application (%), 2023 VS 2030
Figure 36. Europe Oncolytic Virus Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 37. Europe Oncolytic Virus Therapy Sales Value by Type (%), 2023 VS 2030
Figure 38. Europe Oncolytic Virus Therapy Sales Value by Application (%), 2023 VS 2030
Figure 39. China Oncolytic Virus Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 40. China Oncolytic Virus Therapy Sales Value by Type (%), 2023 VS 2030
Figure 41. China Oncolytic Virus Therapy Sales Value by Application (%), 2023 VS 2030
Figure 42. Japan Oncolytic Virus Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 43. Japan Oncolytic Virus Therapy Sales Value by Type (%), 2023 VS 2030
Figure 44. Japan Oncolytic Virus Therapy Sales Value by Application (%), 2023 VS 2030
Figure 45. South Korea Oncolytic Virus Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 46. South Korea Oncolytic Virus Therapy Sales Value by Type (%), 2023 VS 2030
Figure 47. South Korea Oncolytic Virus Therapy Sales Value by Application (%), 2023 VS 2030
Figure 48. Southeast Asia Oncolytic Virus Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 49. Southeast Asia Oncolytic Virus Therapy Sales Value by Type (%), 2023 VS 2030
Figure 50. Southeast Asia Oncolytic Virus Therapy Sales Value by Application (%), 2023 VS 2030
Figure 51. India Oncolytic Virus Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 52. India Oncolytic Virus Therapy Sales Value by Type (%), 2023 VS 2030
Figure 53. India Oncolytic Virus Therapy Sales Value by Application (%), 2023 VS 2030
Figure 54. Oncolytic Virus Therapy Industrial Chain
Figure 55. Oncolytic Virus Therapy Manufacturing Cost Structure
Figure 56. Channels of Distribution (Direct Sales, and Distribution)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation